Pursuant to the completion of the capital distribution exercise of 204,665,784 ordinary shares of CCM Duopharma Biotech Berhad ("CCMD") representing 73.37% of the issued capital of CCMD, to the entitled shareholders of Chemical Company of Malaysia Berhad ("CCMB") on 28 December 2017, the direct shareholding of CCMB in CCMD has reduced to 85,824 ordinary shares representing 0.031% of the issued capital of CCMD and therefore CCMB ceased to be a substantial shareholder of CCMD.